WeVote
Log In

Bill

Bill

SB 706

Opioid antagonist; distribution program, reports.

2026 Regular Session Introduced by Kannan Srinivasan

Virginia establishes opioid antagonist distribution program with reporting requirements to increase overdose reversal access and track public health outcomes.

Governor's recommendation received by Senate (SB706G)
0
WeVote Research Nonpartisan
Bill Summary · SB 706

Legislative bill overview

SB 706 establishes a program in Virginia for the distribution of opioid antagonists (such as naloxone/Narcan) to combat opioid overdose deaths. The bill requires reporting mechanisms to track the program's effectiveness and implementation across the state.

Why is this important

Opioid overdoses remain a leading cause of accidental death in Virginia and nationwide. Wider access to opioid antagonists has been proven to reverse overdoses and save lives, making distribution programs a key public health intervention during the ongoing opioid crisis.

Potential points of contention

  • Funding mechanism unclear – The bill's fiscal impact and how the antagonist distribution program will be funded (state budget, grants, pharmaceutical partnerships) is not specified in available information
  • Implementation scope and oversight – Details about which entities distribute antagonists, training requirements, and accountability mechanisms may lack specificity
  • Access equity concerns – Questions about whether the program adequately reaches rural areas, marginalized communities, and people who use drugs versus prioritizing first responders or institutional settings

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.